{"id":108421,"date":"2021-05-25T11:12:50","date_gmt":"2021-05-25T11:12:50","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=108421"},"modified":"2021-05-25T11:12:50","modified_gmt":"2021-05-25T11:12:50","slug":"carnitine-palmitoyltransferase-deficiency-type-1","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/carnitine-palmitoyltransferase-deficiency-type-1\/","title":{"rendered":"Carnitine palmitoyltransferase deficiency type 1"},"content":{"rendered":"

Carnitine palmitoyltransferase deficiency (CPT) is an extremely rare genetic disorder of mitochondrial fatty-acid oxidation. Two forms of this genetic defect have been described: CPT-I and CPT-II. CPT-I is a more severe form (hepatocardiomuscular syndrome) associated with onset in infancy. CPT-II is a milder form of muscle disease associated with an adult presentation.<\/p>\n

\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Carnitine palmitoyltransferase deficiency (CPT) is an extremely rare genetic disorder of mitochondrial fatty-acid oxidation. Two forms of this genetic defect have been described: CPT-I and CPT-II. CPT-I is a more severe form (hepatocardiomuscular syndrome) associated with onset in infancy. CPT-II is a milder form of muscle disease associated with an adult presentation.  <\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-108421","post","type-post","status-publish","format-standard","hentry","category-c"],"yoast_head":"\nCarnitine palmitoyltransferase deficiency type 1 - Definition of Carnitine palmitoyltransferase deficiency type 1<\/title>\n<meta name=\"description\" content=\"Carnitine palmitoyltransferase deficiency (CPT) is an extremely rare genetic disorder of mitochondrial fatty-acid oxidation. Two forms of this genetic defect have been described: CPT-I and CPT-II. CPT-I is a more severe form (hepatocardiomuscular syndrome) associated with onset in infancy. CPT-II is a milder form of muscle disease associated with an adult presentation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/carnitine-palmitoyltransferase-deficiency-type-1\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Carnitine palmitoyltransferase deficiency type 1 - Definition of Carnitine palmitoyltransferase deficiency type 1\" \/>\n<meta property=\"og:description\" content=\"Carnitine palmitoyltransferase deficiency (CPT) is an extremely rare genetic disorder of mitochondrial fatty-acid oxidation. Two forms of this genetic defect have been described: CPT-I and CPT-II. CPT-I is a more severe form (hepatocardiomuscular syndrome) associated with onset in infancy. CPT-II is a milder form of muscle disease associated with an adult presentation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/carnitine-palmitoyltransferase-deficiency-type-1\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-25T11:12:50+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/carnitine-palmitoyltransferase-deficiency-type-1\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/carnitine-palmitoyltransferase-deficiency-type-1\/\",\"name\":\"Carnitine palmitoyltransferase deficiency type 1 - Definition of Carnitine palmitoyltransferase deficiency type 1\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-05-25T11:12:50+00:00\",\"dateModified\":\"2021-05-25T11:12:50+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Carnitine palmitoyltransferase deficiency (CPT) is an extremely rare genetic disorder of mitochondrial fatty-acid oxidation. Two forms of this genetic defect have been described: CPT-I and CPT-II. CPT-I is a more severe form (hepatocardiomuscular syndrome) associated with onset in infancy. CPT-II is a milder form of muscle disease associated with an adult presentation.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/carnitine-palmitoyltransferase-deficiency-type-1\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/carnitine-palmitoyltransferase-deficiency-type-1\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/carnitine-palmitoyltransferase-deficiency-type-1\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Carnitine palmitoyltransferase deficiency type 1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Carnitine palmitoyltransferase deficiency type 1 - Definition of Carnitine palmitoyltransferase deficiency type 1","description":"Carnitine palmitoyltransferase deficiency (CPT) is an extremely rare genetic disorder of mitochondrial fatty-acid oxidation. Two forms of this genetic defect have been described: CPT-I and CPT-II. CPT-I is a more severe form (hepatocardiomuscular syndrome) associated with onset in infancy. CPT-II is a milder form of muscle disease associated with an adult presentation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/carnitine-palmitoyltransferase-deficiency-type-1\/","og_locale":"en_US","og_type":"article","og_title":"Carnitine palmitoyltransferase deficiency type 1 - Definition of Carnitine palmitoyltransferase deficiency type 1","og_description":"Carnitine palmitoyltransferase deficiency (CPT) is an extremely rare genetic disorder of mitochondrial fatty-acid oxidation. Two forms of this genetic defect have been described: CPT-I and CPT-II. CPT-I is a more severe form (hepatocardiomuscular syndrome) associated with onset in infancy. CPT-II is a milder form of muscle disease associated with an adult presentation.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/carnitine-palmitoyltransferase-deficiency-type-1\/","og_site_name":"Glossary","article_published_time":"2021-05-25T11:12:50+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/carnitine-palmitoyltransferase-deficiency-type-1\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/carnitine-palmitoyltransferase-deficiency-type-1\/","name":"Carnitine palmitoyltransferase deficiency type 1 - Definition of Carnitine palmitoyltransferase deficiency type 1","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-05-25T11:12:50+00:00","dateModified":"2021-05-25T11:12:50+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Carnitine palmitoyltransferase deficiency (CPT) is an extremely rare genetic disorder of mitochondrial fatty-acid oxidation. Two forms of this genetic defect have been described: CPT-I and CPT-II. CPT-I is a more severe form (hepatocardiomuscular syndrome) associated with onset in infancy. CPT-II is a milder form of muscle disease associated with an adult presentation.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/carnitine-palmitoyltransferase-deficiency-type-1\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/carnitine-palmitoyltransferase-deficiency-type-1\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/carnitine-palmitoyltransferase-deficiency-type-1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Carnitine palmitoyltransferase deficiency type 1"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=108421"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108421\/revisions"}],"predecessor-version":[{"id":108422,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108421\/revisions\/108422"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=108421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=108421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=108421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}